Carman Giacomantonio
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Response to Intralesional IL-2 and/or BCG Treatment for Cutaneous Metastatic Melanoma (NCT03928275) | Carman Giacomantonio | 2021-12-01 |
| Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2 (NCT03233828) | Carman Giacomantonio | 2019-10-30 |
Track Carman Giacomantonio automatically
Every clearance here is in the API, with alerts when new ones post.